The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression
结直肠癌中 CD8+ 肿瘤浸润淋巴细胞上的抑制性受体 CD94/NKG2A：HLAE/β2m 过表达背景下一种有前途的新型可用药免疫检查点
期刊:Modern Pathology
影响因子:7.1
doi:10.1038/s41379-019-0322-9
Juliette Eugène #, Nicolas Jouand #, Kathleen Ducoin, Delphine Dansette, Romain Oger, Cécile Deleine, Edouard Leveque, Guillaume Meurette, Juliette Podevin, Tamara Matysiak, Jaafar Bennouna, Stéphane Bezieau, Christelle Volteau, Wassila El Alami Thomas, Jerôme Chetritt, Olivier Kerdraon, Pierre Four
